Archives202520242023202220212020201920182017201620152014201320122011 June 03, 2024Realisation of c£1.5 million on sale of shares in Incanthera plc Read More May 03, 2024TR1 – Major Holding – Lanstead Read More April 24, 2024IMMUPHARMA at BIO-EQUITY 2024 – 12-14 May 2024, San Sebastian Read More April 19, 2024Grant of Share Options Read More April 03, 2024New intellectual property strategy initiated to significantly enhance patent life and commercial value for P140 technology platform Read More March 25, 2024Incanthera Provides Commercial Update and Revenue Forecasts Read More March 19, 2024Grant of Share Options Read More March 14, 2024IMMUPHARMA AT BIO-EUROPE SPRING 2024. 18-20 March 2024 | Barcelona Read More March 06, 2024Financial, Business and Portfolio Development Update Read More January 02, 2024TR1 – Major Holding by Lanstead (Date: 28 December 2023) Read More December 20, 2023TR1 – Major holding by Lanstead Read More December 19, 2023Simbec-Orion appointed as CRO | Decision to move directly into a Phase 3 pivotal study | Compelling findings on P140’s MOA Read More 1234…15
April 03, 2024New intellectual property strategy initiated to significantly enhance patent life and commercial value for P140 technology platform Read More
December 19, 2023Simbec-Orion appointed as CRO | Decision to move directly into a Phase 3 pivotal study | Compelling findings on P140’s MOA Read More
